Published on
December 17, 2018
- 06:00 GMT
Kuros Ends Transformational Year With First MagnetOs Sales, Lead Clinical Program on Track, and Successful Capital Raise
Successfully raised CHF 16.1 million from existing and new investors Funding secured for fibrin-PTH Phase II in spinal fusion, a huge commercial opportunity First sales of MagnetOs in US and Europe, commercial roll-out on track New CFO and CMO bring solid …
Distribution channels:
